The mutation frequency of FGFR3 was lower in the high-stromal group than that in the low-stromal group, suggesting that the smaller the mutation frequency of FGFR3, there may be more tumor stromal cells, thus making the tumor more prone to metastasis. The gene discussed is FGFR3; the disease is neoplasm.